Michael Herschl is a 5th year Ph.D. candidate in the UCSF-UC Berkeley Joint Program in Bioengineering. He develops high-throughput techniques to study epigenetic interactions and develop new combinatorial epigenome editors in the lab of Professor Patrick Hsu at the Arc Institute in Palo Alto, CA. He earned his Bachelor's Degree in Bioengineering from Stanford University in 2019, where he studied the spreading of chromatin-mediated gene silencing in the lab of Professor Lacra Bintu. After completing his Ph.D., Michael hopes to develop next-generation cellular therapeutics to combat diseases like aging, cancer, and autoimmunity.